Megestrol Acetate
- Product NDC
- 0904-7577
- Requested package NDC
- 0904-7577-18
- 11-digit product format
- 009047577
- Labeler code
- 0904
- Product ID
- 0904-7577_1843fe79-7628-4f8e-9b51-e0be7562e43d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Megestrol Acetate
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA077404
- Marketing category
- ANDA
- Marketing start
- 2025-12-29
- Substance
- MEGESTROL ACETATE
- Active strength
- 400 mg/10mL
- Pharmacologic classes
- Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077404-001 | MEGESTROL ACETATE | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077404-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | AB | 2006-02-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A077404-001 | MEGESTROL ACETATE | 40MG/ML | SUSPENSION / ORAL | 2006-02-16 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077404-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A077404-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A077404-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077404-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A077404-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077404-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077404-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077404-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077404-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077404-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077404-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A077404-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077404-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077404-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077404-001 | AB | 1 | 1e350fbaab3a… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A077404-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Megestrol Acetate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MEGESTROL ACETATE | 400 mg/10mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| TJ2M0FR8ES | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 860225 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e44cf173-991b-43cf-93f2-e0efaa4cc29a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 078c5235-b5d8-c448-12aa-7c7688d21da3 | Product name | 3 | 20180205 |
| 1bec0d29-4d8b-21df-403d-4848e3aaa3bc | Product name | 2 | 20170725 |
| 056e8b65-29c9-affb-3d52-7651668fe36b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7577-18 | Megestrol Acetate | 4 in 1 CASE | SUSPENSION | 4 | 2 | |
| 0904-7577-18 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 0904-7577-66 | Megestrol Acetate | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 2 | |
| 0904-7577-72 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 0904-7577-72 | Megestrol Acetate | 10 in 1 CASE | SUSPENSION | 10 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7577-18 | ML - Milliliter | 0904-7577 | 428b9fa4-ee7e-4a59-b922-170745977587 | 1 | 2026-02-05 |
| 0904-7577-66 | ML - Milliliter | 0904-7577 | 91989707-c7e8-4371-8dda-fec52a698768 | 1 | 2026-02-05 |
| 0904-7577-72 | ML - Milliliter | 0904-7577 | a5a455d8-6bba-44fb-864c-5fa3173e1f38 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2026-01-15 | Warnings, Adverse reactions | 077404 ANDA077404 0904-7577-18 0904-7577 00904757718 |
| Megestrol Acetate | MEGESTROL ACETATE | American Health Packaging | 2921731a-6866-4dc8-8f6b-b636abf7bcf8 | 2026-01-05 | Warnings, Adverse reactions | 077404 ANDA077404 |
| Megestrol Acetate | MEGESTROL ACETATE | PAI Holdings, LLC dba PAI Pharma | 2d5b58cd-cbb1-4f5c-b13f-63185c0f8e31 | 2025-10-17 | Warnings, Adverse reactions | 077404 ANDA077404 |
| Megestrol Acetate | MEGESTROL ACETATE | ANI Pharmaceuticals, Inc. | a26dcd78-ad62-4cf5-ad97-49ccb34d43ba | 2024-03-20 | Warnings, Adverse reactions | 077404 ANDA077404 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 860225 | megestrol acetate 40 MG in 1 mL Oral Suspension | PSN | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2 |
| 860225 | megestrol acetate 40 MG/ML Oral Suspension | SCD | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2 |
| 860225 | megestrol acetate 40 MG per 1 ML Oral Suspension | SY | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2 |
| 860225 | megestrol acetate 400 MG per 10 ML Oral Suspension | SY | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2 |
| 860225 | megestrol acetate 800 MG per 20 ML Oral Suspension | SY | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0904-7577-18 | 00904757718 | 4 TRAY in 1 CASE (0904-7577-18) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0904-7577-66) | 4 tray | 2026-01-15 | No | No | Current |